CervoMed Inc. (CRVO)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.54+$0.0200 (+0.79%) on the dayAs of the close; data may be delayed.
CRVO price, last 12 months
Key stats
- Previous close
- $2.52
- Open
- $2.52
- Day range
- $2.52 – $2.63
- 52-week range
- $2.13 – $10.00
- Volume
- 106.1K
- Avg volume (20 days)
- 160.6K
- Market cap
- $38.4M
Performance
1W+4.5%
1M−4.2%
3M−27.2%
6M−35.2%
YTD−67.9%
1Y−68.7%
vs S&P 500, 1Y−85.5 pts
Technicals and fundamentals
About CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $38.4M